Association between heart rate and multiple risk factor syndrome - Cross-sectional analysis of a screened cohort in Okinawa, Japan

Circulation Journal

Volumn 72, Issue 3, 2008, Pages 454-457

  Inoue, Taku ^a,e   Iseki, Kunitoshi ^b   Iseki, Chiho ^b   Ohya, Yusuke ^c   Kinjo, Kozen ^d   Takishita, Shuichi ^c  

^a Cardiovascular Division

^b UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

^c UNIVERSITY OF THE RYUKYUS   (Japan)

^d Okinawa General Health Maintenance Association   (Japan)

^e NONE   (Japan)

Author keywords

Epidemiology; Heart rate; Metabolic syndrome; Multiple risk factors

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; FEMALE; HEART RATE; HIGH RISK POPULATION; HUMAN; JAPAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; METABOLIC SYNDROME X; RISK ASSESSMENT; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; JAPAN; LOGISTIC MODELS; MALE; MASS SCREENING; METABOLIC SYNDROME X; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 42649093827     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.72.454     Document Type: Article

References (24)

1. Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA. Heart rate and cardiovascular mortality: The Framingham Study. Am Heart J 1987; 113: 1489-1494.
2. Gillum RF, Makuc DM, Feldman JJ. Pulse rate, coronary heart disease, and death: The NHANES I Epidemiologic Follow-up Study. Am Heart J 1991; 121: 172-177.
3. Palatini P, Casiglia E, Julius S, Pessina AC. High heart rate: A risk factor for cardiovascular death in elderly men. Arch Intern Med 1999; 159: 585-592.
4. Fujiura Y, Adachi H, Tsumta M, Jacobs DR Jr, Hirai Y, Imaizumi T. Heart rate and mortality in a Japanese general population: An 18-year follow-up study. J Clin Epidemiol 2001; 54: 495-500.
5. Stern MP, Morales PA, Haffner SM, Valdez RA. Hyperdynamic circulation and the insulin resistance syndrome ("syndrome X"). Hypertension 1992; 20: 802-808.
6. Palatini P, Julius S. Heart rate and the cardiovascular risk. J Hypertens 1997; 15: 3-17.
7. Palatini P, Casiglia E, Pauletto P, Staessen J, Kaciroti N, Julius S. Relationship of tachycardia with high blood pressure and metabolic abnormalities: A study with mixture analysis in three populations. Hypertension 1997; 30: 1267-1273.
8. Inoue T, Oshiro S, Iseki K, Tozawa M, Touma T, Ikemiya Y, et al. High heart rate relates to clustering of cardiovascular risk factors in a screened cohort. Jpn Circ J 2001; 65: 969-973.
9. Hanley AJ, Karter AJ, Festa A, D'Agostino R Jr, Wagenknecht LE, Savage P, et al. Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study. Diabetes 2002; 51: 2642-2647.
10. Tanaka H, Shiohira Y, Uezu Y, Higa A, Iseki K. Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int 2006; 69: 369-374.
11. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266.
12. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005; 28: 385-390.
13. Takeuchi H, Saitoh S, Takagi S Ohnishi H, Ohhata J, Isobe T, et al. Metabolic syndrome and cardiac disease in Japanese men: Applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men: The Tanno and Sobetsu Study. Hypertens Res 2005; 28: 203-208.
14. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
15. Tozawa M, Oshiro S, Iseki C, Sesoko S, Higashiuesato Y, Tana T, et al. Multiple risk factor clustering of hypertension in a screened cohort. J Hypertens 2000; 18: 1379-1385.
16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation: Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
17. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004; 24: 29-33.
18. Vollenweider P, Randin D, Tappy L, Jequier E, Nicod P, Scherrer U. Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J Clin Invest 1994; 93: 2365-2371.
19. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor-mediated iegional sympathetic nerve activation by leptin. J Clin Invest 1997; 100: 270-278.
20. Alvarez GE, Beske SD, Ballard TP, Davy KP. Sympathetic neural activation in visceral obesity. Circulation 2002; 106: 2533-2536.
21. Matsuzawa Y, Nakamura T, Shimomura I, Kotani K. Visceral fat accumulation and cardiovascular disease. Obes Res 1995; 3(Suppl): 645S-647S.
22. Kuusisto J, Mykkanen L, Pyorala K, Laakso M. Hyperinsulinemic microalbuminuria: A new risk indicator for coronary heart disease. Circulation 1995; 91: 831-837.
23. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 98: 731-733.
24. Palatini P. Need for a revision of the normal limits of resting heart rate. Hypertension 1999; 33: 622-625.